Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002151
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Randomized Double-Blind Active-Controlled Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28574A in the Treatment of HIV-Infected Patients
Sponsor:
Hoechst Marion Roussel
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
A Randomized Double-Blind Active-Controlled Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28574A in the Treatment of HIV-Infected Patients
Status:
COMPLETED
Status Verified Date:
1996-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To characterize the safety and efficacy of fixed doses of MDL 28574A administered alone and in combination with zidovudine AZT in patients with asymptomatic or mildly symptomatic HIV infection To examine the demographic effects on population pharmacokinetics and pharmacodynamics of MDL 28574A alone and in combination with AZT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NDPR0004 | None | None | None |
| 028574PR0004 | None | None | None |